NCAB Says President’s Budget Would “Seriously Damage” Cancer Program
In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says
Biology Societies Recomend 15% Funding Increase for NIH
Clinical Trials: Data Manager Falsified NSABP Records On 3 Patients, ORI Says
Letter to The Editor: IOM Panel Urges Greater Integration Of Research
Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The future of oncology: Early-career scientists need mentorship and a new academic model
- How will FDA regulate psychedelics?
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- OMB proposal to sideline peer review sparks widespread opposition
Nearly 500,000 public comments flood in—here are some highlights









